Mestecky Jiri, Wright Peter F, Lopalco Lucia, Staats Herman F, Kozlowski Pamela A, Moldoveanu Zina, Alexander Rashada C, Kulhavy Rose, Pastori Claudia, Maboko Leonard, Riedner Gabriele, Zhu Yuwei, Wrinn Terri, Hoelscher Michael
Departments of Microbiology and Medicine, University of Alabama at Birmingham, USA.
AIDS Res Hum Retroviruses. 2011 May;27(5):469-86. doi: 10.1089/aid.2010.0169. Epub 2010 Nov 22.
To address an existing controversy concerning the presence of HIV-1-specific antibodies of the IgA isotype in the female genital tract secretions of highly-exposed but persistently seronegative (HEPSN) women, 41 samples of plasma and cervicovaginal lavage (CVL) fluid were distributed to six laboratories for their blinded evaluation using ELISA with 10 different HIV-1 antigens, chemiluminescence-enhanced Western blots (ECL-WB), and virus neutralization. HIV-specific IgG or IgA antibodies in plasma samples from HEPSN women were absent or detectable only at low levels. In CVL, 11/41 samples displayed low levels of reactivity in ELISA against certain antigens. However, only one sample was positive in two of five laboratories. All but one CVL sample yielded negative results when analyzed by ECL-WB. Viral neutralizing activity was either absent or inconsistently detected in plasma and CVL. Plasma and CVL samples from 26 HIV-1-infected women were used as positive controls. Irrespective of the assays and antigens used, the results generated in all laboratories displayed remarkable concordance in the detection of HIV-1-specific antibodies of the IgG isotype. In contrast, IgA antibodies to HIV-1 antigens were not detected with consistency, and where present, IgA antibodies were at markedly lower levels than IgG. Although HIV-neutralizing activity was detected in plasma of all HIV-1-infected women, only a few of their CVL samples displayed such activity. In conclusion, frequent HIV-1 sexual exposure does not stimulate uniformly detectable mucosal or systemic HIV-1-specific responses, as convincingly documented in the present blindly performed study using a broad variety of immunological assays. Although HIV-1-infection leads to vigorous IgG responses in plasma and CVL, it does not stimulate sustained IgA responses in either fluid.
为解决关于在高暴露但持续血清阴性(HEPSN)女性的女性生殖道分泌物中是否存在IgA同种型HIV-1特异性抗体的现有争议,将41份血浆和宫颈阴道灌洗(CVL)液样本分发给六个实验室,使用10种不同的HIV-1抗原通过酶联免疫吸附测定(ELISA)、化学发光增强免疫印迹法(ECL-WB)和病毒中和试验进行盲法评估。HEPSN女性血浆样本中的HIV特异性IgG或IgA抗体不存在或仅能检测到低水平。在CVL中,11/41份样本在ELISA中对某些抗原显示出低水平反应性。然而,在五个实验室中的两个实验室里,只有一份样本呈阳性。通过ECL-WB分析时,除一份样本外,所有CVL样本均产生阴性结果。血浆和CVL中要么不存在病毒中和活性,要么检测结果不一致。来自26名HIV-1感染女性的血浆和CVL样本用作阳性对照。无论使用何种检测方法和抗原,所有实验室在检测IgG同种型HIV-1特异性抗体时所产生的结果都显示出显著的一致性。相比之下,未一致检测到针对HIV-1抗原的IgA抗体,且即使存在,IgA抗体水平也明显低于IgG。尽管在所有HIV-1感染女性的血浆中都检测到了HIV中和活性,但只有少数她们的CVL样本显示出这种活性。总之,正如本研究使用多种免疫检测方法进行盲法检测令人信服地证明的那样,频繁的HIV-1性暴露不会刺激一致可检测的黏膜或全身性HIV-1特异性反应。尽管HIV-1感染会导致血浆和CVL中产生强烈的IgG反应,但它不会刺激任何一种液体中产生持续的IgA反应。